Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VNDA

Vanda Pharmaceuticals Inc

Jun 18 • 04:00PM ET

5.80

-0.16 -2.68 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NKTR KROS VKTX BMRN INCY RYTM AXSM MDGL KRYS NBIX

| Held by: XBI VTI IWM VXF IWN IBB VTWO SCHA VFMO DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.05	Insider Own	5.43%	Shs Outstand	60.14M	Perf Week	-4.92%
Market Cap	348.79M	Forward P/E	-	EPS next Y	-0.76	Insider Trans	-9.54%	Shs Float	56.87M	Perf Month	-3.17%
Enterprise Value	159.55M	PEG	-	EPS next Q	-0.58	Inst Own	77.42%	Short Float	11.98%	Perf Quarter	-32.32%
Income	-239.55M	P/S	1.60	EPS this Y	39.77%	Inst Trans	6.85%	Short Ratio	5.32	Perf Half Y	-12.78%
Sales	217.78M	P/B	1.24	EPS next Y	66.15%	ROA	-44.97%	Short Interest	6.81M	Perf YTD	-34.24%
Book/sh	4.67	P/C	1.72	EPS next 5Y	45.07%	ROE	-60.48%	52W High	9.94 -41.65%	Perf Year	28.04%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	- -	ROIC	-83.23%	52W Low	4.14 40.10%	Perf 3Y	-8.52%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-5.29% -2.73%	Gross Margin	89.91%	Volatility	5.44% 4.24%	Perf 5Y	-69.74%
Dividend TTM	-	EV/Sales	0.73	EPS Y/Y TTM	-434.76%	Oper. Margin	-73.64%	ATR (14)	0.29	Perf 10Y	-46.59%
Dividend Ex-Date	-	Quick Ratio	2.15	Sales Y/Y TTM	8.16%	Profit Margin	-109.99%	RSI (14)	39.67	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-62.10%	SMA20	-5.28%	Beta	0.61	Target Price	14.12
Payout	-	Debt/Eq	0.05	Sales Q/Q	3.35%	SMA50	-11.38%	Rel Volume	1.35	Prev Close	5.96
Employees	533	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-9.29%	Avg Volume	1.28M	Price	5.80
IPO	Apr 12, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.19% -5.93%	Trades		Volume	1,728,920	Change	-2.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)